118 related articles for article (PubMed ID: 25713884)
1. Serum cytokine levels in patients with colorectal cancers according to tumor stages and VEGF gene polymorphism.
Bayhan Z; Simşek T; Ergül E; Utkan NZ; Canturk NZ; Cekmen M
Hepatogastroenterology; 2014 Oct; 61(135):1889-94. PubMed ID: 25713884
[TBL] [Abstract][Full Text] [Related]
2. Investigation of VEGF and IL-8 Gene Polymorphisms in Patients with Differentiated Thyroid Cancer.
Kilic I; Guldiken S; Sipahi T; Palabiyik O; Akker M; Celik O; Soysal-Atile N; Tuncbilek N; Guven HM; Gundogdu AS; Sut N
Clin Lab; 2016 Dec; 62(12):2319-2325. PubMed ID: 28164553
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-17 may be a valuable serum tumor marker in patients with colorectal carcinoma.
Radosavljevic G; Ljujic B; Jovanovic I; Srzentic Z; Pavlovic S; Zdravkovic N; Milovanovic M; Bankovic D; Knezevic M; Acimovic LJ; Arsenijevic N
Neoplasma; 2010; 57(2):135-44. PubMed ID: 20099977
[TBL] [Abstract][Full Text] [Related]
4. C936T polymorphism of the VEGF gene in relation to the risk and the clinical and biological characteristics of sporadic colorectal adenocarcinoma.
Credidio L; Lima CS; Leal R; de Ayrizono ML; Fagundes JJ; Magna LA; Coy CS
BMC Res Notes; 2014 Oct; 7():768. PubMed ID: 25361753
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of vascular endothelial growth factor gene polymorphisms in patients with colorectal cancer.
Jang MJ; Kim JW; Jeon YJ; Chong SY; Oh D; Kim NK
Int J Clin Oncol; 2013 Dec; 18(6):1032-41. PubMed ID: 23132736
[TBL] [Abstract][Full Text] [Related]
6. Common single nucleotide polymorphisms in the vascular endothelial growth factor gene and colorectal cancer risk.
Hofmann G; Langsenlehner U; Renner W; Langsenlehner T; Yazdani-Biuki B; Clar H; Gerger A; Wehrschuetz M; Samonigg H; Krippl P
J Cancer Res Clin Oncol; 2008 May; 134(5):591-5. PubMed ID: 17938959
[TBL] [Abstract][Full Text] [Related]
7. Prognostic role of serum vascular endothelial growth factor, basic fibroblast growth factor and nitric oxide in patients with colorectal carcinoma.
Akbulut H; Altuntas F; Akbulut KG; Ozturk G; Cindoruk M; Unal E; Icli F
Cytokine; 2002 Nov; 20(4):184-90. PubMed ID: 12543084
[TBL] [Abstract][Full Text] [Related]
8. Serum vascular endothelial growth factor-C and vascular endothelial growth factor level in patients with colorectal carcinoma and clinical significance.
Xu T; Chen D
J Huazhong Univ Sci Technolog Med Sci; 2006; 26(3):329-31, 355. PubMed ID: 16961284
[TBL] [Abstract][Full Text] [Related]
9. Determination of IL-6, TNF-α and VEGF levels in the serums of patients with colorectal cancer.
Coşkun Ö; Öztopuz Ö; Özkan ÖF
Cell Mol Biol (Noisy-le-grand); 2017 May; 63(5):97-101. PubMed ID: 28719352
[TBL] [Abstract][Full Text] [Related]
10. The association of VEGF rs833061 and rs2010963 polymorphisms with susceptibility to colorectal cancer in an Iranian population.
Bakhshian-Dehkordi E; Safaei M; Fattahi S; Faghani M; Deris F; Chaleshtori MH
Cancer Epidemiol; 2021 Dec; 75():102041. PubMed ID: 34592532
[TBL] [Abstract][Full Text] [Related]
11. Clinical relevance of serum vascular endothelial growth factor and interleukin-6 in patients with colorectal cancer.
Eldesoky A; Shouma A; Mosaad Y; Elhawary A
Saudi J Gastroenterol; 2011; 17(3):170-3. PubMed ID: 21546718
[TBL] [Abstract][Full Text] [Related]
12. Relationship between plasma levels of vascular endothelial growth factor and serum levels of interleukin-12 in patients with colorectal cancer.
Nakayama Y; Sako T; Shibao K; Onitsuka K; Nagashima N; Hirata K; Nagata N; Itoh H
Anticancer Res; 2000; 20(6A):4097-102. PubMed ID: 11131678
[TBL] [Abstract][Full Text] [Related]
13. C-reactive protein, procalcitonin, interleukin-6, vascular endothelial growth factor and oxidative metabolites in diagnosis of infection and staging in patients with gastric cancer.
Ilhan N; Ilhan N; Ilhan Y; Akbulut H; Kucuksu M
World J Gastroenterol; 2004 Apr; 10(8):1115-20. PubMed ID: 15069709
[TBL] [Abstract][Full Text] [Related]
14. Preoperative serum vascular endothelial growth factor can predict stage in colorectal cancer.
Kumar H; Heer K; Lee PW; Duthie GS; MacDonald AW; Greenman J; Kerin MJ; Monson JR
Clin Cancer Res; 1998 May; 4(5):1279-85. PubMed ID: 9607588
[TBL] [Abstract][Full Text] [Related]
15. Research on the relationship between serum levels of inflammatory cytokines and non-small cell lung cancer.
Song XY; Zhou SJ; Xiao N; Li YS; Zhen DZ; Su CY; Liu ZD
Asian Pac J Cancer Prev; 2013; 14(8):4765-8. PubMed ID: 24083740
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of serum vascular endothelial growth factor and complement 3a levels in patients with colorectal cancer in southern Iran.
Mehrabani D; Shamsdin SA; Dehghan A; Safarpour A
Asian Pac J Cancer Prev; 2014; 15(22):9713-7. PubMed ID: 25520093
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor gene polymorphisms and colorectal cancer risk: a meta-analysis.
Zhou LP; Luan H; Dong XH; Jin GJ; Man DL; Shang H
Genet Mol Res; 2011 Oct; 10(4):3674-88. PubMed ID: 22058001
[TBL] [Abstract][Full Text] [Related]
18. Genetic variants in CCL5 and CCR5 genes and serum VEGF-A levels predict efficacy of bevacizumab in metastatic colorectal cancer patients.
Suenaga M; Cao S; Zhang W; Yang D; Ning Y; Okazaki S; Berger MD; Miyamoto Y; Schirripa M; Soni S; Barzi A; Yamaguchi T; Lenz HJ
Int J Cancer; 2019 May; 144(10):2567-2577. PubMed ID: 30411783
[TBL] [Abstract][Full Text] [Related]
19. [Clinical value of preoperative serum VEGF, CRP and IL-6 levels in colorectal carcinoma].
Li ZP; Han JQ; Meng XW; Yang YF
Zhonghua Zhong Liu Za Zhi; 2010 Oct; 32(10):795-9. PubMed ID: 21163075
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-10 -592C/A, but not -1082A/G promoter single nucleotide polymorphism, is associated with a decreased risk of colorectal cancer in an ethnic Kashmiri population: a case-control study.
Banday MZ; Sameer AS; Chowdri NA; Haq E
Eur J Cancer Prev; 2017 Nov; 26(6):476-490. PubMed ID: 28538040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
